Dalid, Jerlyn T.

HRN: 06-30-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2026
CEFUROXIME 500MG (TAB)
06/29/2026
07/06/2026
ORAL
500mg
BID
S/P CS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: